About StromaGenesis Informing Precise Therapy


StromaGenesis, LLC, founded in 2022 by Dr. Richard Pestell, is a clinical‑stage biotech company advancing precision oncology by targeting the tumor microenvironment. It has developed a proprietary prostate cancer prognostic algorithm and tissue‑ and blood‑based immunoassays that predict therapy response and act as companion diagnostics for solid tumors such as breast, colon, prostate, and glioblastoma.

The platform offers investors a scalable, de‑risked approach with multiple near‑to‑mid‑term opportunities in the growing precision‑medicine market.

For more details, visit here: www.stromagenesis.com

Comments

Post a Comment

Popular posts from this blog

Richard Pestell - A Physician Scientist

Image
Dr. Richard G. Pestell , AO, is a physician-scientist, cancer researcher, and biotech leader. Holding MD, PhD, and MBA degrees, he commands global respect for his transformative contributions to oncology. As CEO of EcoGenome and Dean at Xavier University, his work continues to drive safer, more effective cancer therapies, inspired by a personal loss to the disease. Dr. Richard G. Pestell’s trailblazing work in oncology spans continents and disciplines. From academia to biotech, he’s shaped global cancer care. CEO of EcoGenome and Dean of Xavier University School of Medicine, his career reflects dedication, excellence, and personal purpose. An Officer of the Order of Australia, he works tirelessly to improve lives through science.  
Read more

Beyond the Clinic: Why Every Oncology Specialist Should Embrace Philanthropy

Cancer care has evolved dramatically over the last few decades. With advances in precision medicine, immunotherapy, and early detection, oncology specialists now play a central role not only in treatment but also in long-term survivorship and quality-of-life planning. Their influence extends beyond hospital walls into communities, research institutions, and policy discussions that shape the future of care. As the responsibilities of oncology specialists expand, so does their potential to make an impact beyond traditional clinical duties. Philanthropy offers a meaningful avenue for these professionals to address systemic gaps, fund innovation, and improve access to care. By engaging in charitable initiatives, oncology specialists can amplify their expertise and drive broader-scale change that benefits patients. Strengthening Access to Care Many cancer patients face significant barriers to treatment, including financial hardship, transportation challenges, and limited access to speciali...
Read more

Leading for Healing: Why the Union of Medicine and Leadership Drives Meaningful Social Change

The intersection of medicine and leadership plays a vital role in shaping healthier, more equitable societies where progress depends on informed action and compassionate direction. Although clinical skills allow medical professionals to treat individuals, leadership skills empower them to influence systems and inspire broad improvements in community well-being. As healthcare challenges grow more complex, health equity leadership becomes essential for addressing barriers and guiding collaborative solutions. Additionally, effective leaders bridge the gap between medical expertise and social responsibility to create environments that support lasting transformation. Ultimately, this powerful combination of roles strengthens public trust and drives positive change across generations. Understanding the Social Impact of Medical Influence Medical professionals often carry significant influence because communities rely on them for essential guidance and trusted information. They witness firsth...
Read more